Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Braz. j. med. biol. res ; 48(6): 568-576, 06/2015. tab, graf
Article in English | LILACS | ID: lil-748228

ABSTRACT

Remote ischemic preconditioning (RIPre) can prevent myocardial injury. The purpose of this study was to assess the beneficial effects of long-term regular RIPre on human arteries. Forty patients scheduled for coronary artery bypass graft (CABG) surgery were assigned randomly to a RIPre group (n=20) or coronary heart disease (CHD) group (n=20). Twenty patients scheduled for mastectomy were enrolled as a control group. RIPre was achieved by occluding arterial blood flow 5 min with a mercury sphygmomanometer followed by a 5-min reperfusion period, and this was repeated 4 times. The RIPre procedure was repeated 3 times a day for 20 days. In all patients, arterial fragments discarded during surgery were collected to evaluate endothelial function by flow-mediated dilation (FMD), CD34+ monocyte count, and endothelial nitric oxide synthase (eNOS expression). Phosphorylation levels of STAT-3 and Akt were also assayed to explore the underlying mechanisms. Compared with the CHD group, long-term regular RIPre significantly improved FMD after 20 days (8.5±2.4 vs 4.9±4.2%, P<0.05) and significantly reduced troponin after CABG surgery (0.72±0.31 and 1.64±0.19, P<0.05). RIPre activated STAT-3 and increased CD34+ endothelial progenitor cell counts found in arteries. Long-term, regular RIPre improved endothelial function in patients with CHD, possibly due to STAT-3 activation, and this may have led to an increase in endothelial progenitor cells.


Subject(s)
Aged , Female , Humans , Male , Middle Aged , Coronary Disease/physiopathology , Coronary Disease/prevention & control , Endothelium, Vascular/physiopathology , Ischemic Preconditioning, Myocardial/methods , /analysis , Blotting, Western , Coronary Artery Bypass/methods , Coronary Disease/surgery , Endothelial Progenitor Cells , Flow Cytometry/methods , Immunohistochemistry , Leukocyte Count , Myocardial Infarction/physiopathology , Myocardial Infarction/prevention & control , Nitric Oxide Synthase Type III/analysis , Real-Time Polymerase Chain Reaction , /analysis , Statistics, Nonparametric , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL